O antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections.
Prevention of Klebsiella infections by passive immunotherapy has received more attention during the last decade. Both K antigen-and O antigen-specific antisera and monoclonal antibodies (mAbs) have been studied with respect to phagocytosis-enhancing and in vivo protective capacities. Our own work has focussed on the generation of O serogroup-specific rabbit antisera and O antigen specific murine antibodies. O-specific rabbit sera were absorbed extensively with heterologous O antigen strains in order to obtain highly specific typing reagents. Using these for typing a collection of 378 clinical strains, we found that 82% of them belonged to one of the four serogroups O1, O2ab, O3 and O5. Phagocytosis experiments using antisera and mAbs showed that O antigen specific antibodies were able to opsonize non-encapsulated strains, while fully encapsulated bacteria were rather resistant against the opsonizing effect. Nevertheless, in vivo experiments demonstrated a prophylactic effect on both Klebsiella septicemia and pneumonia in a mouse model of lethal infection. Given the limited number of O serogroups, O antigen-specific antibodies may be suited to supplement K antigen-specific hyperimmune globulins for passive immunoprophylaxis of Klebsiella infections.
Trautmann
M
M
Institute of Hospital Hygiene, Klinikum Stuttgart, D-70174 Stuttgart, Germany. mtrautmann@katharinenhospital.de
Held
T K
TK
Cross
A S
AS
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D007709:Klebsiella / Q000276:immunology*; D007710:Klebsiella Infections / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control*; D051379:Mice; D019081:O Antigens / Q000276:immunology* / Q000302:isolation & purification; D009895:Opsonin Proteins; D011817:Rabbits; D012703:Serotyping
D000911:Antibodies, Monoclonal; D019081:O Antigens; D009895:Opsonin Proteins